NZ274179A - 3-(cyclic amide-methenyl)-1h-2-carboxy-indole derivatives - Google Patents

3-(cyclic amide-methenyl)-1h-2-carboxy-indole derivatives

Info

Publication number
NZ274179A
NZ274179A NZ274179A NZ27417994A NZ274179A NZ 274179 A NZ274179 A NZ 274179A NZ 274179 A NZ274179 A NZ 274179A NZ 27417994 A NZ27417994 A NZ 27417994A NZ 274179 A NZ274179 A NZ 274179A
Authority
NZ
New Zealand
Prior art keywords
compound
solution
indole
dichloro
oxo
Prior art date
Application number
NZ274179A
Other languages
English (en)
Inventor
Alfredo Cugola
Fabio Romano Di
Giorgio Pentassuglia
Original Assignee
Glaxo Wellcome Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Spa filed Critical Glaxo Wellcome Spa
Publication of NZ274179A publication Critical patent/NZ274179A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
NZ274179A 1993-10-14 1994-10-12 3-(cyclic amide-methenyl)-1h-2-carboxy-indole derivatives NZ274179A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939321221A GB9321221D0 (en) 1993-10-14 1993-10-14 Heterocyclic compounds
PCT/EP1994/003359 WO1995010517A1 (en) 1993-10-14 1994-10-12 Indole derivatives as nmda antagonists

Publications (1)

Publication Number Publication Date
NZ274179A true NZ274179A (en) 1998-01-26

Family

ID=10743550

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ274179A NZ274179A (en) 1993-10-14 1994-10-12 3-(cyclic amide-methenyl)-1h-2-carboxy-indole derivatives

Country Status (27)

Country Link
US (3) US5760059A (Sortimente)
EP (1) EP0723541A1 (Sortimente)
JP (1) JPH09503770A (Sortimente)
CN (1) CN1070490C (Sortimente)
AP (1) AP574A (Sortimente)
AU (1) AU681194B2 (Sortimente)
BG (1) BG61839B1 (Sortimente)
CA (1) CA2171449A1 (Sortimente)
CO (1) CO4290355A1 (Sortimente)
CZ (1) CZ92396A3 (Sortimente)
FI (1) FI961628A7 (Sortimente)
GB (1) GB9321221D0 (Sortimente)
HU (1) HU219710B (Sortimente)
IL (1) IL111294A (Sortimente)
IS (1) IS4219A (Sortimente)
MY (1) MY112411A (Sortimente)
NO (1) NO309861B1 (Sortimente)
NZ (1) NZ274179A (Sortimente)
OA (1) OA10578A (Sortimente)
PE (1) PE21995A1 (Sortimente)
PL (1) PL179568B1 (Sortimente)
RU (1) RU2144535C1 (Sortimente)
SG (1) SG49013A1 (Sortimente)
SK (1) SK44996A3 (Sortimente)
TW (1) TW283144B (Sortimente)
WO (1) WO1995010517A1 (Sortimente)
ZA (1) ZA947948B (Sortimente)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9321221D0 (en) * 1993-10-14 1993-12-01 Glaxo Spa Heterocyclic compounds
GB9704498D0 (en) * 1997-03-05 1997-04-23 Glaxo Wellcome Spa Chemical compound
GB9704499D0 (en) * 1997-03-05 1997-04-23 Glaxo Wellcome Spa Method of manufacture
WO2000056711A1 (en) * 1999-03-23 2000-09-28 Sumitomo Pharmaceuticals Co., Ltd. Tricyclic indole-2-carboxylic acid compound used as nmda receptor antagonist
RU2209041C2 (ru) * 2000-06-15 2003-07-27 Новосибирский научно-исследовательский институт травматологии и ортопедии Способ лечения церебрального вазоспазма
DE10153346A1 (de) 2001-10-29 2004-04-22 Grünenthal GmbH Substituierte Indole
US20030162825A1 (en) * 2001-11-09 2003-08-28 Sepracor Inc. D-amino acid oxidase inhibitors for learning and memory
WO2005066135A2 (en) 2003-12-29 2005-07-21 Sepracor Inc. Pyrrole and pyrazole daao inhibitors
AU2006264317B2 (en) 2005-07-06 2012-02-23 Sunovion Pharmaceuticals Inc. Combinations of eszopiclone and trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-napthalenamine or trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders
CN101321749A (zh) * 2005-12-01 2008-12-10 霍夫曼-拉罗奇有限公司 新插烯酸衍生物
NZ569630A (en) * 2006-01-06 2011-09-30 Sepracor Inc Cycloalkylamines as monoamine reuptake inhibitors
CN104276955A (zh) * 2006-01-06 2015-01-14 赛诺维信制药公司 基于四氢萘酮的单胺再摄取抑制剂
AU2007233041B2 (en) 2006-03-31 2013-05-02 Sepracor Inc. Preparation of chiral amides and amines
US7884124B2 (en) * 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
US7579370B2 (en) * 2006-06-30 2009-08-25 Sepracor Inc. Fused heterocycles
US20080082066A1 (en) * 2006-10-02 2008-04-03 Weyerhaeuser Co. Crosslinked carboxyalkyl cellulose fibers having non-permanent and temporary crosslinks
US7902252B2 (en) * 2007-01-18 2011-03-08 Sepracor, Inc. Inhibitors of D-amino acid oxidase
MX2009007410A (es) * 2007-01-18 2009-09-09 Sepracor Inc Inhibidores de d-aminoacido oxidasa.
WO2008151156A1 (en) 2007-05-31 2008-12-11 Sepracor Inc. Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors
WO2010017418A1 (en) * 2008-08-07 2010-02-11 Sepracor Inc. Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
KR20110126132A (ko) * 2009-03-10 2011-11-22 산텐 세이야꾸 가부시키가이샤 4,6-디클로로-1η-인돌-2-카르복실산 유도체 또는 이의 염을 유효 성분으로서 함유하는 시신경 장애의 예방 또는 치료제
WO2011017634A2 (en) * 2009-08-07 2011-02-10 Sepracore Inc. Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
CA2850707C (en) 2011-10-03 2023-03-21 The University Of Utah Research Foundation Application of 5-ht6 receptor antagonists for the alleviation of cognitive deficits of down syndrome
USRE49340E1 (en) 2014-04-30 2022-12-20 Yufeng Jane Tseng Use of known compounds as D-amino acid oxidase inhibitors
CA3207747A1 (en) 2016-09-14 2018-03-22 Yufeng Jane Tseng Novel substituted benzimidazole derivatives as d-amino acid oxidase (daao) inhibitors

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256673A (en) * 1983-11-25 1993-10-26 Merck Patent Gesellschaft Mit Beschrankter Haftung Indole-3-yl-A-tetrahydropyridyl or piperidyl compounds
US4960786A (en) * 1989-04-24 1990-10-02 Merrell Dow Pharmaceuticals Inc. Excitatory amino acid antagonists
PT93943A (pt) * 1989-05-05 1991-02-08 Searle & Co Processo para a preparacao de composicoes contendo compostos indole-2-carboxilato para tratamento de perturbacoes do snc
DE4101686A1 (de) * 1991-01-22 1992-07-23 Merck Patent Gmbh Indolderivate
US5284862A (en) * 1991-03-18 1994-02-08 Warner-Lambert Company Derivatives of 2-carboxyindoles having pharmaceutical activity
US5145845A (en) * 1991-05-14 1992-09-08 Warner-Lambert Co. Substituted 2-carboxylindoles having pharmaceutical activity
EP0545478A1 (en) * 1991-12-03 1993-06-09 MERCK SHARP & DOHME LTD. Heterocyclic compounds as tachykinin antagonists
GB9208492D0 (en) * 1992-04-16 1992-06-03 Glaxo Spa Heterocyclic compounds
ZA936492B (en) * 1992-09-10 1995-03-02 Lilly Co Eli Compounds useful as hypoglycemic agents and for treating Alzheimer's disease.
DE4333254A1 (de) * 1993-09-30 1995-04-06 Merck Patent Gmbh Piperidine und Piperazine
GB9321221D0 (en) * 1993-10-14 1993-12-01 Glaxo Spa Heterocyclic compounds

Also Published As

Publication number Publication date
NO961475D0 (no) 1996-04-12
EP0723541A1 (en) 1996-07-31
AU7813394A (en) 1995-05-04
NO309861B1 (no) 2001-04-09
IL111294A (en) 1998-12-06
JPH09503770A (ja) 1997-04-15
HUT76065A (en) 1997-06-30
CN1133042A (zh) 1996-10-09
US6100289A (en) 2000-08-08
FI961628A0 (fi) 1996-04-12
TW283144B (Sortimente) 1996-08-11
RU2144535C1 (ru) 2000-01-20
IS4219A (is) 1995-04-15
BG100511A (en) 1996-11-29
OA10578A (en) 2002-06-07
AP9400685A0 (en) 1994-10-31
GB9321221D0 (en) 1993-12-01
US5760059A (en) 1998-06-02
AU681194B2 (en) 1997-08-21
NO961475L (no) 1996-04-12
IL111294A0 (en) 1994-12-29
SK44996A3 (en) 1997-01-08
MY112411A (en) 2001-06-30
SG49013A1 (en) 1998-05-18
AP574A (en) 1997-01-30
FI961628A7 (fi) 1996-04-12
CZ92396A3 (en) 1996-08-14
HU9600969D0 (en) 1996-06-28
CA2171449A1 (en) 1995-04-20
US5962496A (en) 1999-10-05
CO4290355A1 (es) 1996-04-17
PL179568B1 (pl) 2000-09-29
CN1070490C (zh) 2001-09-05
WO1995010517A1 (en) 1995-04-20
ZA947948B (en) 1995-05-23
PL313969A1 (en) 1996-08-05
PE21995A1 (es) 1995-08-14
HU219710B (hu) 2001-06-28
BG61839B1 (bg) 1998-07-31

Similar Documents

Publication Publication Date Title
NZ274179A (en) 3-(cyclic amide-methenyl)-1h-2-carboxy-indole derivatives
AP480A (en) 3-Substituted indole 2-carboxylic acid derivatives.
AU2009247262B2 (en) Amide compound
TWI386405B (zh) 咪唑衍生物
AU708291B2 (en) Indole derivatives as EAA antagonists
CN101903342B (zh) 取代的n-苯基-吡咯烷基甲基吡咯烷酰胺及其作为组胺h3受体调节剂的治疗用途
WO2006022454A1 (ja) 塩基性基を含有する化合物およびその用途
AP877A (en) Tetrahydroquinoline derivatives as EAA antagonists.
WO2006040646A1 (en) Benzimidazole or indole amides as inhibitors of pin1
JPH08507300A (ja) 興奮性アミノ酸の拮抗剤としてのインドール誘導体
KR20130141500A (ko) 단백질 키나제 억제 활성을 갖는 신규한 아미노퀴나졸린 화합물
JP2001510441A (ja) ホスホジエステラーゼ4阻害剤としてのジアゼピノインドール
KR20220061119A (ko) MAGL 억제제로서 4,4a,5,7,8,8a-헥사피리도[4,3-b][1,4]옥사진-3-온 화합물
WO2011091410A1 (en) Trpv4 antagonists
WO2011091407A1 (en) Trpv4 antagonists
CZ340599A3 (cs) Derivát kyseliny chinolin-2-karboxylové